M/S Madras Petrochem Ltd. v. Bifr .

Court

Supreme Court of India

Decided

29 January 2016

Case no.

C.A. No.-000614-000615 - 2016

Bench

Kurian Joseph,Rohinton Fali Nariman

Facts

• The appellant company, M/s Madras Petrochem Ltd., was declared sick under the Sick Industrial Companies (Special Provisions) Act, 1985, after its net worth eroded completely.
• A rehabilitation scheme was sanctioned in 1991, which ultimately failed, leading to a second scheme that also failed by 2000.
• BIFR recommended winding up the company in 2001, which was confirmed by the AAIFR in 2002.
• Concurrently, ICICI Bank initiated proceedings under the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest Act, 2002, issuing notices for possession and sale of the company's assets.
• The appellants filed a writ petition challenging the BIFR and AAIFR orders, which was initially stayed by the Delhi High Court but was ultimately dismissed in 2008.

Arguments

Petitioner Arguments

The appellants argued that

• The BIFR and AAIFR orders were unjustified as they had not been given a fair opportunity to present a viable rehabilitation scheme.
• The actions taken by ICICI under the Securitisation Act were premature and violated the provisions of the Sick Industrial Companies Act.

Critique: The court addressed these arguments by emphasizing the prolonged period of protection under the Sick Industrial Companies Act and the repeated failures of rehabilitation schemes. The court found that the appellants had ample opportunity to present their case but failed to do so satisfactorily.

Respondent Arguments

The respondents, including BIFR and ICICI, contended that

• The appellant company had exhausted all avenues for rehabilitation, with two failed schemes over a span of years.
• The winding up was necessary to protect the interests of creditors and stakeholders, given the company's inability to recover.

Critique: The court supported the respondents' arguments, highlighting the statutory mandate of the BIFR to ensure that companies do not remain under protection indefinitely without a viable plan for recovery. The court noted the necessity of balancing the interests of creditors against the continued existence of a non-viable company.

Precedents considered

The judgment did not explicitly cite prior cases but relied on established legal principles under the Sick Industrial Companies Act and the Securitisation Act. The court's reasoning was grounded in the statutory framework that governs the winding up of sick companies and the rights of secured creditors.

Legal principles

Key legal principles considered included

• The criteria for declaring a company as "sick" under the Sick Industrial Companies Act.
• The procedural requirements for rehabilitation and the implications of repeated failures to present viable schemes.
• The rights of secured creditors under the Securitisation Act, particularly in relation to the winding up of a company.

Decision and reasoning

Rationale

The court reasoned that the prolonged protection under the Sick Industrial Companies Act without a viable rehabilitation plan justified the winding up of the appellant company. The court emphasized the need for timely action to protect the interests of creditors and the economy, noting that the failure of two rehabilitation schemes indicated a lack of potential for recovery.

Outcome

The Supreme Court dismissed the appeals, upholding the orders of the BIFR and AAIFR for the winding up of M/s Madras Petrochem Ltd. The court did not provide specific instructions for the appeal process, as the dismissal was final.

Conclusion

This judgment underscores the importance of timely and effective rehabilitation measures for sick companies and the rights of creditors in the context of insolvency. It reinforces the legal framework governing sick industrial companies and the necessity for companies to demonstrate viability to avoid winding up.

Read the full judgment on the Supreme Court website (PDF)